VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $232,000 | -5.3% | 10,000 | -35.1% | 0.01% | -36.4% |
| Q1 2018 | $245,000 | -99.3% | 15,400 | -91.8% | 0.02% | -98.5% |
| Q3 2015 | $33,321,000 | +3.6% | 186,798 | +29.1% | 1.44% | -18.7% |
| Q2 2015 | $32,151,000 | -23.3% | 144,727 | -31.4% | 1.77% | +1.1% |
| Q1 2015 | $41,896,000 | +413.5% | 210,934 | +239.2% | 1.75% | +391.3% |
| Q3 2014 | $8,159,000 | -28.1% | 62,190 | -30.9% | 0.36% | -31.2% |
| Q2 2014 | $11,351,000 | -17.8% | 90,000 | -23.5% | 0.52% | +2.4% |
| Q4 2013 | $13,816,000 | +12.5% | 117,681 | 0.0% | 0.51% | +1.8% |
| Q3 2013 | $12,278,000 | +21.2% | 117,681 | 0.0% | 0.50% | +21.8% |
| Q2 2013 | $10,130,000 | – | 117,681 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |